 | • レポートコード：QFJ1-5928 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、パニック発作治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害薬（SSRI）、セロトニンノルエピネフリン再取り込み阻害薬（SNRI）、ベンゾジアゼピン（BZD））、用途別市場規模（病院、メンタルヘルスケアセンター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・パニック発作治療の市場動向 ・企業の競争状況、市場シェア ・パニック発作治療の種類別市場規模と予測2016-2027（選択的セロトニン再取り込み阻害薬（SSRI）、セロトニンノルエピネフリン再取り込み阻害薬（SNRI）、ベンゾジアゼピン（BZD）） ・パニック発作治療の用途別市場規模と予測2016-2027（病院、メンタルヘルスケアセンター、その他） ・パニック発作治療の北米市場規模2016-2027（アメリカ、カナダ） ・パニック発作治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・パニック発作治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・パニック発作治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・パニック発作治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline plc.、F. Hoffmann-La Roche Ltd、Actavis Generics、Noven Pharmaceuticals, Inc.、Recordati Rare Diseases(Recordati)、Shionogi & Co., Ltd.、Abbott Laboratories、Sumitomo Dainippon Pharma、Pfizer,Inc.、Bristol Myers Squibb(BMS)、Baxter International Inc.、Eli Lilly and Company） ・結論 |
Panic attacks are caused when patients feel with sudden surge of overwhelming anxiety and fear.
Market Analysis and Insights: Global Panic Attack Treatment Market
The global Panic Attack Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Panic Attack Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Panic Attack Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Panic Attack Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Panic Attack Treatment market.
Global Panic Attack Treatment Scope and Market Size
Panic Attack Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Panic Attack Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Selective Serotonin Reuptake Inhibitor(SSRI)
Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Benzodiazepines(BZD)
Segment by Application
Hospitals
Mental Healthcare Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Actavis Generics
Noven Pharmaceuticals, Inc.
Recordati Rare Diseases(Recordati)
Shionogi & Co., Ltd.
Abbott Laboratories
Sumitomo Dainippon Pharma
Pfizer,Inc.
Bristol Myers Squibb(BMS)
Baxter International Inc.
Eli Lilly and Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Panic Attack Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Selective Serotonin Reuptake Inhibitor(SSRI)
1.2.3 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
1.2.4 Benzodiazepines(BZD)
1.3 Market by Application
1.3.1 Global Panic Attack Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Mental Healthcare Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Panic Attack Treatment Market Perspective (2016-2027)
2.2 Panic Attack Treatment Growth Trends by Regions
2.2.1 Panic Attack Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Panic Attack Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Panic Attack Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Panic Attack Treatment Industry Dynamic
2.3.1 Panic Attack Treatment Market Trends
2.3.2 Panic Attack Treatment Market Drivers
2.3.3 Panic Attack Treatment Market Challenges
2.3.4 Panic Attack Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Panic Attack Treatment Players by Revenue
3.1.1 Global Top Panic Attack Treatment Players by Revenue (2016-2021)
3.1.2 Global Panic Attack Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Panic Attack Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Panic Attack Treatment Revenue
3.4 Global Panic Attack Treatment Market Concentration Ratio
3.4.1 Global Panic Attack Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Panic Attack Treatment Revenue in 2020
3.5 Panic Attack Treatment Key Players Head office and Area Served
3.6 Key Players Panic Attack Treatment Product Solution and Service
3.7 Date of Enter into Panic Attack Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Panic Attack Treatment Breakdown Data by Type
4.1 Global Panic Attack Treatment Historic Market Size by Type (2016-2021)
4.2 Global Panic Attack Treatment Forecasted Market Size by Type (2022-2027)
5 Panic Attack Treatment Breakdown Data by Application
5.1 Global Panic Attack Treatment Historic Market Size by Application (2016-2021)
5.2 Global Panic Attack Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Panic Attack Treatment Market Size (2016-2027)
6.2 North America Panic Attack Treatment Market Size by Type
6.2.1 North America Panic Attack Treatment Market Size by Type (2016-2021)
6.2.2 North America Panic Attack Treatment Market Size by Type (2022-2027)
6.2.3 North America Panic Attack Treatment Market Size by Type (2016-2027)
6.3 North America Panic Attack Treatment Market Size by Application
6.3.1 North America Panic Attack Treatment Market Size by Application (2016-2021)
6.3.2 North America Panic Attack Treatment Market Size by Application (2022-2027)
6.3.3 North America Panic Attack Treatment Market Size by Application (2016-2027)
6.4 North America Panic Attack Treatment Market Size by Country
6.4.1 North America Panic Attack Treatment Market Size by Country (2016-2021)
6.4.2 North America Panic Attack Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Panic Attack Treatment Market Size (2016-2027)
7.2 Europe Panic Attack Treatment Market Size by Type
7.2.1 Europe Panic Attack Treatment Market Size by Type (2016-2021)
7.2.2 Europe Panic Attack Treatment Market Size by Type (2022-2027)
7.2.3 Europe Panic Attack Treatment Market Size by Type (2016-2027)
7.3 Europe Panic Attack Treatment Market Size by Application
7.3.1 Europe Panic Attack Treatment Market Size by Application (2016-2021)
7.3.2 Europe Panic Attack Treatment Market Size by Application (2022-2027)
7.3.3 Europe Panic Attack Treatment Market Size by Application (2016-2027)
7.4 Europe Panic Attack Treatment Market Size by Country
7.4.1 Europe Panic Attack Treatment Market Size by Country (2016-2021)
7.4.2 Europe Panic Attack Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Panic Attack Treatment Market Size (2016-2027)
8.2 Asia-Pacific Panic Attack Treatment Market Size by Type
8.2.1 Asia-Pacific Panic Attack Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Panic Attack Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Panic Attack Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Panic Attack Treatment Market Size by Application
8.3.1 Asia-Pacific Panic Attack Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Panic Attack Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Panic Attack Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Panic Attack Treatment Market Size by Region
8.4.1 Asia-Pacific Panic Attack Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Panic Attack Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Panic Attack Treatment Market Size (2016-2027)
9.2 Latin America Panic Attack Treatment Market Size by Type
9.2.1 Latin America Panic Attack Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Panic Attack Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Panic Attack Treatment Market Size by Type (2016-2027)
9.3 Latin America Panic Attack Treatment Market Size by Application
9.3.1 Latin America Panic Attack Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Panic Attack Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Panic Attack Treatment Market Size by Application (2016-2027)
9.4 Latin America Panic Attack Treatment Market Size by Country
9.4.1 Latin America Panic Attack Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Panic Attack Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Panic Attack Treatment Market Size (2016-2027)
10.2 Middle East & Africa Panic Attack Treatment Market Size by Type
10.2.1 Middle East & Africa Panic Attack Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Panic Attack Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Panic Attack Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Panic Attack Treatment Market Size by Application
10.3.1 Middle East & Africa Panic Attack Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Panic Attack Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Panic Attack Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Panic Attack Treatment Market Size by Country
10.4.1 Middle East & Africa Panic Attack Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Panic Attack Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc.
11.1.1 GlaxoSmithKline plc. Company Details
11.1.2 GlaxoSmithKline plc. Business Overview
11.1.3 GlaxoSmithKline plc. Panic Attack Treatment Introduction
11.1.4 GlaxoSmithKline plc. Revenue in Panic Attack Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline plc. Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Panic Attack Treatment Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Panic Attack Treatment Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Actavis Generics
11.3.1 Actavis Generics Company Details
11.3.2 Actavis Generics Business Overview
11.3.3 Actavis Generics Panic Attack Treatment Introduction
11.3.4 Actavis Generics Revenue in Panic Attack Treatment Business (2016-2021)
11.3.5 Actavis Generics Recent Development
11.4 Noven Pharmaceuticals, Inc.
11.4.1 Noven Pharmaceuticals, Inc. Company Details
11.4.2 Noven Pharmaceuticals, Inc. Business Overview
11.4.3 Noven Pharmaceuticals, Inc. Panic Attack Treatment Introduction
11.4.4 Noven Pharmaceuticals, Inc. Revenue in Panic Attack Treatment Business (2016-2021)
11.4.5 Noven Pharmaceuticals, Inc. Recent Development
11.5 Recordati Rare Diseases(Recordati)
11.5.1 Recordati Rare Diseases(Recordati) Company Details
11.5.2 Recordati Rare Diseases(Recordati) Business Overview
11.5.3 Recordati Rare Diseases(Recordati) Panic Attack Treatment Introduction
11.5.4 Recordati Rare Diseases(Recordati) Revenue in Panic Attack Treatment Business (2016-2021)
11.5.5 Recordati Rare Diseases(Recordati) Recent Development
11.6 Shionogi & Co., Ltd.
11.6.1 Shionogi & Co., Ltd. Company Details
11.6.2 Shionogi & Co., Ltd. Business Overview
11.6.3 Shionogi & Co., Ltd. Panic Attack Treatment Introduction
11.6.4 Shionogi & Co., Ltd. Revenue in Panic Attack Treatment Business (2016-2021)
11.6.5 Shionogi & Co., Ltd. Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Panic Attack Treatment Introduction
11.7.4 Abbott Laboratories Revenue in Panic Attack Treatment Business (2016-2021)
11.7.5 Abbott Laboratories Recent Development
11.8 Sumitomo Dainippon Pharma
11.8.1 Sumitomo Dainippon Pharma Company Details
11.8.2 Sumitomo Dainippon Pharma Business Overview
11.8.3 Sumitomo Dainippon Pharma Panic Attack Treatment Introduction
11.8.4 Sumitomo Dainippon Pharma Revenue in Panic Attack Treatment Business (2016-2021)
11.8.5 Sumitomo Dainippon Pharma Recent Development
11.9 Pfizer,Inc.
11.9.1 Pfizer,Inc. Company Details
11.9.2 Pfizer,Inc. Business Overview
11.9.3 Pfizer,Inc. Panic Attack Treatment Introduction
11.9.4 Pfizer,Inc. Revenue in Panic Attack Treatment Business (2016-2021)
11.9.5 Pfizer,Inc. Recent Development
11.10 Bristol Myers Squibb(BMS)
11.10.1 Bristol Myers Squibb(BMS) Company Details
11.10.2 Bristol Myers Squibb(BMS) Business Overview
11.10.3 Bristol Myers Squibb(BMS) Panic Attack Treatment Introduction
11.10.4 Bristol Myers Squibb(BMS) Revenue in Panic Attack Treatment Business (2016-2021)
11.10.5 Bristol Myers Squibb(BMS) Recent Development
11.11 Baxter International Inc.
11.11.1 Baxter International Inc. Company Details
11.11.2 Baxter International Inc. Business Overview
11.11.3 Baxter International Inc. Panic Attack Treatment Introduction
11.11.4 Baxter International Inc. Revenue in Panic Attack Treatment Business (2016-2021)
11.11.5 Baxter International Inc. Recent Development
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Panic Attack Treatment Introduction
11.12.4 Eli Lilly and Company Revenue in Panic Attack Treatment Business (2016-2021)
11.12.5 Eli Lilly and Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Panic Attack Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Selective Serotonin Reuptake Inhibitor(SSRI)
Table 3. Key Players of Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Table 4. Key Players of Benzodiazepines(BZD)
Table 5. Global Panic Attack Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Panic Attack Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Panic Attack Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Panic Attack Treatment Market Share by Regions (2016-2021)
Table 9. Global Panic Attack Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Panic Attack Treatment Market Share by Regions (2022-2027)
Table 11. Panic Attack Treatment Market Trends
Table 12. Panic Attack Treatment Market Drivers
Table 13. Panic Attack Treatment Market Challenges
Table 14. Panic Attack Treatment Market Restraints
Table 15. Global Panic Attack Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Panic Attack Treatment Market Share by Players (2016-2021)
Table 17. Global Top Panic Attack Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panic Attack Treatment as of 2020)
Table 18. Ranking of Global Top Panic Attack Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Panic Attack Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Panic Attack Treatment Product Solution and Service
Table 22. Date of Enter into Panic Attack Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Panic Attack Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Panic Attack Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Panic Attack Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Panic Attack Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Panic Attack Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Panic Attack Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Panic Attack Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Panic Attack Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Panic Attack Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Panic Attack Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Panic Attack Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Panic Attack Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Panic Attack Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Panic Attack Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Panic Attack Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Panic Attack Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Panic Attack Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Panic Attack Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Panic Attack Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Panic Attack Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Panic Attack Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Panic Attack Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Panic Attack Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Panic Attack Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Panic Attack Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Panic Attack Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Panic Attack Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Panic Attack Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Panic Attack Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Panic Attack Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Panic Attack Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Panic Attack Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Panic Attack Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Panic Attack Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Panic Attack Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Panic Attack Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Panic Attack Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Panic Attack Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline plc. Company Details
Table 63. GlaxoSmithKline plc. Business Overview
Table 64. GlaxoSmithKline plc. Panic Attack Treatment Product
Table 65. GlaxoSmithKline plc. Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline plc. Recent Development
Table 67. F. Hoffmann-La Roche Ltd Company Details
Table 68. F. Hoffmann-La Roche Ltd Business Overview
Table 69. F. Hoffmann-La Roche Ltd Panic Attack Treatment Product
Table 70. F. Hoffmann-La Roche Ltd Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 71. F. Hoffmann-La Roche Ltd Recent Development
Table 72. Actavis Generics Company Details
Table 73. Actavis Generics Business Overview
Table 74. Actavis Generics Panic Attack Treatment Product
Table 75. Actavis Generics Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 76. Actavis Generics Recent Development
Table 77. Noven Pharmaceuticals, Inc. Company Details
Table 78. Noven Pharmaceuticals, Inc. Business Overview
Table 79. Noven Pharmaceuticals, Inc. Panic Attack Treatment Product
Table 80. Noven Pharmaceuticals, Inc. Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 81. Noven Pharmaceuticals, Inc. Recent Development
Table 82. Recordati Rare Diseases(Recordati) Company Details
Table 83. Recordati Rare Diseases(Recordati) Business Overview
Table 84. Recordati Rare Diseases(Recordati) Panic Attack Treatment Product
Table 85. Recordati Rare Diseases(Recordati) Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 86. Recordati Rare Diseases(Recordati) Recent Development
Table 87. Shionogi & Co., Ltd. Company Details
Table 88. Shionogi & Co., Ltd. Business Overview
Table 89. Shionogi & Co., Ltd. Panic Attack Treatment Product
Table 90. Shionogi & Co., Ltd. Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 91. Shionogi & Co., Ltd. Recent Development
Table 92. Abbott Laboratories Company Details
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Panic Attack Treatment Product
Table 95. Abbott Laboratories Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 96. Abbott Laboratories Recent Development
Table 97. Sumitomo Dainippon Pharma Company Details
Table 98. Sumitomo Dainippon Pharma Business Overview
Table 99. Sumitomo Dainippon Pharma Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 100. Sumitomo Dainippon Pharma Recent Development
Table 101. Pfizer,Inc. Company Details
Table 102. Pfizer,Inc. Business Overview
Table 103. Pfizer,Inc. Panic Attack Treatment Product
Table 104. Pfizer,Inc. Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 105. Pfizer,Inc. Recent Development
Table 106. Bristol Myers Squibb(BMS) Company Details
Table 107. Bristol Myers Squibb(BMS) Business Overview
Table 108. Bristol Myers Squibb(BMS) Panic Attack Treatment Product
Table 109. Bristol Myers Squibb(BMS) Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 110. Bristol Myers Squibb(BMS) Recent Development
Table 111. Baxter International Inc. Company Details
Table 112. Baxter International Inc. Business Overview
Table 113. Baxter International Inc. Panic Attack Treatment Product
Table 114. Baxter International Inc. Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 115. Baxter International Inc. Recent Development
Table 116. Eli Lilly and Company Company Details
Table 117. Eli Lilly and Company Business Overview
Table 118. Eli Lilly and Company Panic Attack Treatment Product
Table 119. Eli Lilly and Company Revenue in Panic Attack Treatment Business (2016-2021) & (US$ Million)
Table 120. Eli Lilly and Company Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Panic Attack Treatment Market Share by Type: 2020 VS 2027
Figure 2. Selective Serotonin Reuptake Inhibitor(SSRI) Features
Figure 3. Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Features
Figure 4. Benzodiazepines(BZD) Features
Figure 5. Global Panic Attack Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Mental Healthcare Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Panic Attack Treatment Report Years Considered
Figure 10. Global Panic Attack Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Panic Attack Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Panic Attack Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Panic Attack Treatment Market Share by Regions (2022-2027)
Figure 14. Global Panic Attack Treatment Market Share by Players in 2020
Figure 15. Global Top Panic Attack Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panic Attack Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Panic Attack Treatment Revenue in 2020
Figure 17. Global Panic Attack Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Panic Attack Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Panic Attack Treatment Market Share by Type (2016-2027)
Figure 21. North America Panic Attack Treatment Market Share by Application (2016-2027)
Figure 22. North America Panic Attack Treatment Market Share by Country (2016-2027)
Figure 23. United States Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Panic Attack Treatment Market Share by Type (2016-2027)
Figure 27. Europe Panic Attack Treatment Market Share by Application (2016-2027)
Figure 28. Europe Panic Attack Treatment Market Share by Country (2016-2027)
Figure 29. Germany Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Panic Attack Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Panic Attack Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Panic Attack Treatment Market Share by Region (2016-2027)
Figure 39. China Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Panic Attack Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Panic Attack Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Panic Attack Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Panic Attack Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Panic Attack Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Panic Attack Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Panic Attack Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GlaxoSmithKline plc. Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 60. Actavis Generics Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 61. Noven Pharmaceuticals, Inc. Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 62. Recordati Rare Diseases(Recordati) Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 63. Shionogi & Co., Ltd. Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 65. Sumitomo Dainippon Pharma Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 66. Pfizer,Inc. Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 67. Bristol Myers Squibb(BMS) Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 68. Baxter International Inc. Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 69. Eli Lilly and Company Revenue Growth Rate in Panic Attack Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の選択的セロトニン再取り込み阻害薬（SSRI）市場規模・現状・予測（2021年-2027年） Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do. With an increase in mental illnesses, there is…- 選択的セロトニン再取り込み阻害薬（SSRI）のグローバル市場：規模・現状・予測2019-2025 Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is …
- 選択的セロトニン再取り込み阻害薬（SSRI）のグローバル市場：規模・現状・予測2019-2025 Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is …
- 世界の睡眠麻痺治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sleep Paralysis Treatment Market The global Sleep Paralysis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界のCARASIL治療市場規模・現状・予測（2021年-2027年） Carasil is distinguishing by injury to the small blood vessels within the brain as well as the destruction of myelin in the central nervous system. Carasil treatment is an immensely rare genetic disorder in which individuals with carasil are exposing to risk associating with numerous strokes as well…